OR WAIT null SECS
July 08, 2009
As the pharmaceutical industry turns its efforts to biologic-based drugs and to more targeted delivery approaches, new tools are needed. Some recent developments are discussed.
July 02, 2009
Formulators and manufacturers have many options for modifying release profiles in multiple-API products.
Also, Wyeth and Catalyst sign agreement; FDA seeks public opinion about tobacco regulation; Catalent appoints VP of quality and regulatory affairs; more...
Pan coating has been the preferred method of coating tablets for more than 20 years, but core coating is becoming more popular.
The regulators are doing it. But industry's fear of sharing information may leave them behind.
The authors review various oral drug delivery systems that have been explored to increase patient compliance for insulin.
Is it good policy to pay for bad behavior?
June 25, 2009
Also, Adimab forms deals with Merck and Roche; Manhattan Pharmaceuticals' CEO and president steps down; more...
June 18, 2009
Also, FDA debars clinical investigators; Jubilant Organosys forms deal with Endo Pharmaceuticals; AMRI makes changes to its India management team; more...
June 11, 2009
Also, TorreyPines Therapeutics to liquidate assets and dissolve company; EU's competition services to examine Pfizer/Wyeth merger; Akorn appoints Raj Rai interim CEO; more...